2206 Bull. Chem. Soc. Jpn., 76, No. 11 (2003)
Enantioselective 1,3-Dipolar Cycloaddition
29
Cl2NO2: Mþ = 337.0636. Found: m=z 337.0620. ½ꢀꢃD ꢁ55:1ꢂ
(c 0.487, CHCl3). HPLC (Chiralcel OD-H, 2-propanol 3.0% in
hexane, Flow 1.0 mL/min, 11.4 min (major), 18.0 min (minor),
82% ee, (S,S)-6).
137.0, 143.5, 151.9; IR (NaCl) 3442, 3022, 2922, 1597, 1489,
1448, 1421, 1041, 754, 694 cmꢁ1
. HRMS: Calcd for C24H24-
28
Cl2NO2: (M + 1)þ = 428.1184. Found: m=z 428.1205. ½ꢀꢃD
ꢁ75:4ꢂ (c 0.991, CHCl3). HPLC (Chiralpak AD-H, EtOH 2.0%
in hexane, Flow 1.0 mL/min, 13.2 min (major), 26.0 min (minor),
90% ee, (S,S)-6).
ꢀ
ꢀ
(3R ,5R )-5-Butyl-3-(2,3-dichlorophenyl)-5-hydroxymeth-
yl-2-phenylisoxazolidine (110): 1H NMR (CDCl3) ꢃ 0.90 (3H, t,
J ¼ 7:1 Hz), 1.20–1.47 (4H, m), 1.59–1.70 (1H, m), 1.78 (1H, t,
J ¼ 6:7 Hz), 1.82–1.93 (1H, m), 2.06 (1H, dd, J ¼ 8:1, 12.7
Hz), 3.03 (1H, dd, J ¼ 8:1, 12.7 Hz), 3.47 (1H, dd, J ¼ 6:7, 12.0
Hz), 3.58 (1H, dd, J ¼ 6:7, 12.0 Hz), 5.11 (1H, t, J ¼ 8:1 Hz),
6.81–6.86 (2H, m), 6.90 (1H, t, J ¼ 7:8 Hz), 7.17–7.26 (3H, m),
7.39 (1H, dd, J ¼ 1:5, 7.8 Hz), 7.64 (1H, dd, J ¼ 1:5, 7.8 Hz);
13C NMR (CDCl3) ꢃ 14.0, 23.2, 26.5, 34.7, 44.3, 64.7, 66.0, 86.6
113.6, 121.2, 125.8, 127.9, 129.0, 129.2, 130.0, 133.1, 142.1,
150.5; IR (NaCl) 3431, 2956, 2870, 1599, 1490, 1450, 1419,
ꢀ
ꢀ
ꢀ
Transformation of 3g into 3a. Silylation of (1R ,4R ,5R )-
4-(2-Bromophenyl)-5-hydroxymethyl-3-phenyl-2-oxa-3-azabi-
ꢀ
ꢀ
ꢀ
cyclo[3.3.0]octane (3g): To a solution of (1R ,4R ,5R )-4-(2-
bromophenyl)-5-hydroxymethyl-3-phenyl-2-oxa-3-azabicyclo-
[3.3.0]octane (3g, 70.6 mg, 0.189 mmol) in DMF (2.5 mL) was
added imidazole (38.4 mg, 0.56 mmol) and tert-butyldimethylsilyl
chloride (87.2 mg, 0.58 mmol) at 0 ꢂC. The reaction mixture was
then warmed to r.t. and stirred for 12 h. Standard work-up and
chromatography on silica gel (Hexane:AcOEt = 40:1) afforded
the corresponding silyl ether 3g0 (85.1 mg) in 92% yield.
1041, 785, 752, 694 cmꢁ1
. HRMS: Calcd for C20H22Cl2NO2:
(M ꢁ 1)þ = 378.1027. Found: m=z 378.0999. ½ꢀꢃD ꢁ64:5ꢂ (c
0.684, CHCl3). HPLC (Chiralcel OD-H, 2-propanol 5.0% in hex-
ane, Flow 1.0 mL/min, 6.0 min (major), 7.6 min (minor), 79% ee,
(S,S)-6).
(1R ,4R ,5R )-4-(2-Bromophenyl)-5-(tert-butyldimethylsil-
oxymethyl)-3-phenyl-2-oxa-3-azabicyclo[3.3.0]octane
(3g0):
28
ꢀ
ꢀ
ꢀ
1H NMR (CDCl3) ꢃ ꢁ0:143 (3H, s), ꢁ0:136 (3H, s), 0.75 (9H,
s), 1.07–1.14 (1H, m), 1.25–1.56 (4H, m), 1.97–2.02 (1H, m),
3.63 (1H, d, J ¼ 9:3 Hz), 3.70 (1H, d, J ¼ 9:3 Hz), 4.71–4.72
(1H, m), 5.21 (1H, s) 6.87 (1H, t, J ¼ 7:3 Hz), 6.96 (1H, d, J ¼
7:3 Hz), 7.13 (1H, dt, J ¼ 1:5, 7.8, 13.7 Hz), 7.21–7.20 (2H, m),
7.31 (1H, t, J ¼ 7:3 Hz), 7.55 (1H, dd, J ¼ 1:5, 8.1 Hz), 7.81
(1H, dd, J ¼ 1:5, 7.8 Hz); 13C NMR (CDCl3) ꢃ 18.3, 25.2,
25.75, 25.85, 30.67, 30.70, 67.0, 67.6, 75.0, 88.5, 113.3, 120.6,
123.3, 127.3, 128.5, 128.9, 130.1, 131.9, 140.1, 151.1; IR (NaCl)
3066, 2954, 2928, 2856, 1596, 1487, 1469, 1440, 1361, 1254,
ꢀ
ꢀ
(3R ,5R )-3-(2,3-Dichlorophenyl)-5-hexyl-5-hydroxymeth-
yl-2-phenylisoxazolidine (120): 1H NMR (CDCl3) ꢃ 0.87 (3H, t,
J ¼ 6:8 Hz), 1.15–1.48 (8H, m), 1.55–1.71 (1H, m), 1.74–1.94
(1H, m), 2.05 (1H, dd, J ¼ 7:6, 12.4 Hz), 3.03 (1H, dd, J ¼ 8:5,
12.4 Hz), 3.46 (1H, dd, J ¼ 5:1, 12.1 Hz), 3.57 (1H, dd, J ¼ 5:9,
12.1 Hz), 5.11 (1H, t, J ¼ 8:0 Hz), 6.83 (2H, d, J ¼ 7:8 Hz),
6.90 (1H, t, J ¼ 7:6 Hz), 7.15–7.30 (3H, m), 7.39 (1H, dd,
J ¼ 1:5, 8.3 Hz), 7.63 (1H, dd, J ¼ 1:5, 8.1 Hz); 13C NMR
(CDCl3) ꢃ 14.1, 22.6, 24.3, 29.8, 31.7, 34.9, 44.3, 64.7, 66.0,
86.6, 113.6, 121.2, 125.8, 127.9, 129.0, 129.1, 130.0, 133.1,
142.0, 150.5; IR (NaCl) 3444, 2929, 2858, 1599, 1491, 1419,
1271, 1041, 752, 694 cmꢁ1. HRMS: Calcd for C22H27Cl2NO2:
1105, 839, 779, 749, 695 cmꢁ1
.
Debromination of 3g0: Under nitrogen atmosphere, to a solu-
tion of the silyl ether 3g0 (45 mg, 0.092 mmol) in THF (1.5 mL)
was added n-butyllithium (1.58 M (1 M = 1 mol dmꢁ3) solution
in hexane, 0.1 mL) at ꢁ78 ꢂC. The mixture was stirred for 5
min, followed by treatment with water and warmed to room
temperature. The organic extracts were concentrated to afford
the crude debrominated product. The debrominated silyl ether
was treated with tetrabutylammonium fluoride (1 mol/L in THF,
2 mL) and stirred for 30 min at room temperature. Standard
work-up and chromatography on silica gel (Hexane:AcOEt =
Mþ = 407.1419. Found: m=z 407.1406. ½ꢀꢃD ꢁ63:0ꢂ (c
27
0.552, CHCl3). HPLC (Chiralcel OD-H, 2-propanol 3.0% in hex-
ane, Flow 1.0 mL/min, 7.0 min (major), 12.7 min (minor), 77% ee,
(S,S)-6).
(3S,5S)-3-(2,3-Dichlorophenyl)-5-hydroxymethyl-5-benzyl-
2-phenylisoxazolidine (130): 1H NMR (CDCl3) ꢃ 1.84 (1H, s),
2.12 (1H, dd, J ¼ 7:6, 12.5 Hz), 2.94 (1H, d, J ¼ 13:7 Hz), 2.98
(1H, dd, J ¼ 8:8, 12.5 Hz), 3.24 (1H, d, J ¼ 13:7 Hz), 3.44 (1H,
dd, J ¼ 5:6, 12.0 Hz), 3.51 (1H, dd, J ¼ 5:6, 12.0 Hz), 5.05 (1H,
t, J ¼ 8:3 Hz), 6.84 (2H, d, J ¼ 7:8 Hz), 6.92 (1H, t, J ¼ 7:8
Hz), 7.14 (1H, t, J ¼ 7:8 Hz), 7.18–7.33 (7H, m), 7.38 (1H, dd,
J ¼ 1:5, 7.8 Hz), 7.48 (1H, dd, J ¼ 1:5, 7.8 Hz); 13C NMR
(CDCl3) ꢃ 41.0, 44.0, 64.2, 65.9, 86.1, 114.2, 121.5, 125.8,
126.6, 128.0, 128.2, 128.9, 129.2, 130.0, 130.3, 133.0, 136.3,
141.8, 150.1; IR (NaCl) 3444, 3028, 2927, 1712, 1597, 1489,
1261, 1041, 752, 528 cmꢁ1. HRMS: Calcd for C23H21Cl2NO2:
ꢀ
ꢀ
ꢀ
4:1) afforded (1R ,4S ,5R )-5-hydroxymethyl-3,4-diphenyl-2-
oxa-3-azabicyclo[3.3.0]octane (3a, 25.0 mg) in 92% yield. HPLC
(Chiralpak AD-H, 2-propanol 2.0% in hexane, Flow 1.0 mL/min,
21.3 min (major), 32.1 min (minor), 87% ee, corresponding to
(S,S)-6).
Preparation of 15: To a solution of 2,4-dinitrophenylhydra-
zine (55.2 mg, 0.28 mmol) and sulfuric acid (370 mg) in H2O
(0.3 mL)–EtOH (1 mL), was added a solution of aldehyde (95.7
mg, 0.23 mmol), precursor of cycloadduct 130, in MeOH (15
mL) under nitrogen atmosphere. After 10 min at room tempera-
ture, the precipitate was filtered to afford the product, (3S,5S)-5-
benzyl-3-(2,3-dichlorophenyl)-5-(2,4-dinitrophenylhydrazono)-2-
phenylisoxazolidine (15), in 95% yield (130.0 mg).
X-ray Analysis of 15: The crystals were grown from THF–
hexane solution over the course of one day. A crystal specimen
of suitable approximate dimensions was chosen. The X-ray inten-
sities were measured on a Rigaku AFC-7R diffractometer with
Mo Kꢀ radiation. The structure was solved by direct methods us-
ing SIR92 and refined by full-matrix least-squares calculations on
F2 using SHELXL-97. The refinement of the absolute configura-
tions was performed and the structure presented yielded a value of
ꢁ0:1ð2Þ for the Flack parameter, indicating that the structure had
the correct absolute configurations.
Mþ = 413.0962. Found: m=z 413.0997. ½ꢀꢃD ꢁ84:1ꢂ (c
29
0.895, CHCl3). HPLC (Chiralpak AD-H, 2-propanol 10.0% in
hexane, Flow 1.0 mL/min, 10.2 min (major), 11.6 min (minor),
92% ee, (S,S)-6).
ꢀ
ꢀ
(3R ,5R )-3-(2,3-Dichlorophenyl)-5-hydroxymethyl-5-(4-
methylbenzyl)-2-phenylisoxazolidine (140): 1H NMR (CDCl3) ꢃ
1.89 (1H, s), 2.15 (1H, dd, J ¼ 8:3, 12.7 Hz), 2.31 (3H, s), 2.88
(1H, d, J ¼ 13:7 Hz), 2.96 (1H, dd, J ¼ 8:3, 12.7 Hz), 3.20 (1H,
d, J ¼ 13:7 Hz), 3.42 (1H, d, J ¼ 11:7 Hz), 3.50 (1H, d, J ¼
11:7 Hz), 5.04 (1H, t, J ¼ 8:3 Hz), 6.81–6.87 (2H, m), 6.91 (1H,
t, J ¼ 7:3 Hz), 7.05–7.17 (5H, m), 7.18–7.25 (2H, m), 7.37 (1H,
dd, J ¼ 1:6, 8.2 Hz), 7.50 (1H, dd, J ¼ 1:6, 8.2 Hz); 13C NMR
(CD3OD) ꢃ 21.2, 41.2, 44.8, 65.0, 67.1, 87.4, 115.6, 122.3,
127.4, 129.1, 129.5, 129.6, 130.1, 130.9, 131.6, 133.9, 134.9,